Concepedia

A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer

Geneviève Bouchard‐Fortier, Barry P. Rosen, Iryna Vyarvelska, Mark Pasetka, Allan Covens, Lilian T. Gien, Rachel Kupets, Katherine Pulman, Sarah E. Ferguson, Danielle Vicus

Gynecologic Oncology · 2015 · 21 citations · 20 references

Concepts

MedicineGynecologyOncologyChemotherapyGynecologic OncologyMedical OncologyChemotherapy Drug AdministrationChemotherapy Toxicity ManagementCytotoxic ChemotherapyOvarian CancerOvarian NeoplasiaToxicity ManagementChemotherapy-induced Ovarian ToxicityOvarian Cancer ChemotherapyOvarian Cancer Clinical TrialsOvarian Cancer Treatment

References

20

Cancer statistics, 2012

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel et al. · New England Journal of Medicine · 2006 · 2.6K citations · Full text

Medicine, Gynecology, Oncology +14

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

Medicine, Gynecology, Oncology +17

Carcinoma of the Ovary

APM Heintz, Franco Odicino, Patrick Maisonneuve et al. · International Journal of Gynecology & Obstetrics · 2006 · 1.3K citations

Medicine, Gynecology, Oncology +10

Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

David S. Alberts, P. Y. Liu, Edward V. Hannigan et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text

Medicine, Oncology, Surgery +5